| Total (n = 287) | Urosepsis group (n = 41) | Non-urosepsis group (n = 246) | P value |
---|---|---|---|---|
Age (yr) | 53.81 ± 11.89 | 53.80 ± 11.18 | 53.81 ± 12.02 | 0.997 |
Females | 179 (62.4%) | 28 (68.3%) | 151 (61.4%) | 0.398 |
Rural | 223 (77.7%) | 36 (87.8%) | 187 (76.0%) | 0.093 |
Education (yr) | ||||
 ≤ 6 | 96 (33.4%) | 16 (39.0%) | 80 (32.5%) | 0.704 |
 16–12 | 160 (55.7%) | 21 (51.2%) | 139 (56.5%) |  |
 ≥ 12 | 31 (10.8%) | 4 (9.8%) | 27 (11.0%) |  |
 Smoking | 53 (19.6%)a | 7 (17.1%) | 46 (20.0%) | 0.663 |
Comorbidity | ||||
 DM | 28 (9.8%) | 2 (4.9%) | 26 (10.6%) | 0.394 |
 Hypertension | 51 (17.8%) | 4 (9.8%) | 47 (19.1%) | 0.147 |
 CHD | 12 (4.2%) | 2 (4.9%) | 10 (4.1%) | 1.000 |
 CKD | 82 (28.6%) | 12 (29.3%) | 70 (28.5%) | 0.915 |
ASA classification | ||||
 I-II | 144 (50.5%)a | 11 (27.5%) | 133 (54.3%) | 0.002** |
 III | 141 (49.5%)a | 29 (72.5%) | 112 (45.7%) |  |